Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

INSP

Inspire Medical Systems, Inc.

Surgical & Medical Instruments & Apparatus · SIC 3841CIK 1609550Held by 2 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$912.0M
Net Income FY2025
$145.0M
EPS (Basic, as reported)
$4.95
Net Margin FY2025
15.9%
ROE FY2025
18.6%
Total Equity
$781.0M
Shares Out
29M
Business description

Inspire Medical Systems, Inc. — Surgical & Medical Instruments & Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2016–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 16 → 912 +56.7% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue16295182115233408625803912
Cost of revenue(4)(6)(10)(14)(18)(33)(66)(97)(123)(133)
Gross profit1323416898200342528680779
Research & development(7)(6)(7)(13)(26)(37)(69)(117)(114)(103)
Selling, general & administrative(23)(32)(54)(90)(128)(203)(321)(452)(530)(625)
Total operating expenses(30)(39)(61)(103)(154)(240)(389)(568)——
Operating income(17)(16)(20)(35)(56)(40)(48)(40)3651
Interest expense(1)(2)(3)(2)(2)(2)(2)000
Interest & investment income0024105212318
Other income (expense), net(1)(2)(1)2(1)(2)3202215
Pre-tax income(19)(18)(22)(33)(57)(42)(44)(20)5866
Income tax expense000000(1)(1)(5)(80)
Net income(19)(18)(22)(33)(57)(42)(45)(21)54145
EPS — basic———($1.40)($2.19)($1.54)($1.60)($0.72)$1.80$4.95
EPS — diluted———($1.40)($2.19)($1.54)($1.60)($0.72)$1.75$4.89
Shares outstanding — basic (M)———24262728293029
Shares outstanding — diluted (M)———24262728293130

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.